Provided by Tiger Trade Technology Pte. Ltd.

Turnstone Biologics Corp.

0.3550
0.0000
Volume:- -
Turnover:101.65K
Market Cap:8.21M
PE:-0.17
High:0.3550
Open:0.3550
Low:0.3550
Close:0.3550
52wk High:2.40
52wk Low:0.2900
Shares:23.14M
Float Shares:19.93M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0463
EPS(LYR):-3.0749
ROE:-126.71%
ROA:-57.78%
PB:0.56
PE(LYR):-0.12

Loading ...

Company Profile

Company Name:
Turnstone Biologics Corp.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.